Max Planck Institute   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Munich Germany (1911)

Organization Overview

First Clinical Trial
2001
NCT00520026
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Max-Planck Institut | Max Planck Institute for Human Cognitive and Brain Sciences | Max Planck Institute for Infection Biology | Max Planck Institute for Infection Biology (MPIIB), Berlin, Germany | Max-Planck Institute for Metabolism Research | Max-Planck-Institute, Munich | Max-Planck-Institute of Experimental Medicine | Max-Planck-Institute of Psychiatry | Max Planck Institute of Psychiatry, Munich | Max-Planck-Institute of Psychiatry Munich